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 For many decades, cardiac rehabilitation (CR) and exercise training (ET;CRET) programs have 
been indicated in patients with coronary heart disease (CHD) following major CHD events and 
revascularization procedures, 1,2   but this therapy is greatly under-utilized. 3. More recently, this therapy 
has become indicated for patients with chronic systolic heart failure (HF). 4  Although especially in CHD, 
there may be benefits of other components of CR, by far the main component is the ET with 
improvements in cardiorespiratory fitness (CRF), which likely explains most of the benefits of CR in CHD 
and HF. Typically, phase II CRET programs begin early following major cardiovascular disease (CVD ) 
events, and consists of 36 education and ET sessions, performed 3 times weekly in the CR center for 12 
weeks, which is similar to the CR programs used following  heart transplantation (HT). 
 
 In the present issue of JHLT, Bachmann and colleagues5 reported on 2,531 HT patients in the US 
in 2013, specifically examining 595 (24%) under Medicare coverage, demonstrating that 55% 
participated in formal CRET programs, with higher use in the Midwest and increasing rates over time 
from 2008 to 2013.  Although they "spin" this as a disappointment, saying "only half of HT recipients 
participate in CR programs in the US," the 55% participation is actually extremely high compared to most 
assessments of patients with CHD and HF.  In addition to CR participation increasing, they also 
demonstrated increasing  numbers of individual CRET sessions actually attended.  More importantly, 
they demonstrated that hospital re-admissions at 1-year were reduced by 29% in those who 
participated in formal CRET compared with non-participants. 
 
 Although Bachmann and colleagues5 stated several limitations of their study, which included 
representing only 24% of HT recipients in 2013 and only including fee for service Medicare recipients, a 
more substantial limitation is that these data were from a large database that does not allow for 
assessment of all potential confounders and is not nearly as valuable as randomized controlled data.  
Selection bias could be present in that those who freely decided to attend formal CRET after HT 
compared to non-participants, who may have different characteristics and levels of motivation.  
Importantly, the causes of hospitalizations were unavailable, and it is probably rare to be readmitted for 
“frailty” or “failure to thrive”, which further raises the possibility of “enrollment bias” or confounding 
due to selection of healthier individuals for CR participation.  Nevertheless, these data add to that from 
a recent analysis of 201 HT recipients at Mayo Clinic, where amazingly 93.5% attended at least one CRET 
session (mean 14±8 sessions).6  Rosenbaum and colleagues6 reported from this cohort that the number 
of CR sessions attended in the first 90 days after HT predicted survival in multivariate regression, even 
correcting for CRF (assessed by 6-minute walk test) and rejection episodes (hazard ratio 0.90; 95% CI, 
0.82-0.97; p=0.007), suggesting for the first time an association between CR and long-term survival in 
patients after HT.  Although the mean number of CR sessions attended was far lower than the standard 
36 session CRET programs, attending 8 or more sessions was associated with survival post-HT, with 
incrementally greater survival for each session beyond 8 attended.6  A recent Cochrane review of ET-
based CR after HT assessed 10 randomized controlled trials of 300 participants, indicating that CR 
following HT significantly improved measures of CRF ( peak oxygen consumption or VO2 ) , although 
there was no impact in this meta-analysis on health-related quality of life from the CR. 7 
 
 We8-10 and others11 have also reported numerous benefits of ET after HT, including 
improvements in pulmonary oxygen uptake kinetics, skeletal muscle function, and particularly aerobic 
capacity, including peak VO2, which likely explains much of the benefits noted with CRET following HT.  
Likely, the improvement in peak VO2 is mostly from peak arterial-venous oxygen differences being 
higher after CRET due to improvements in peripheral mechanics, including improved microvascular 
and/or skeletal muscle function, as previously demonstrated in older patients with HF and preserved 
ejection fraction.12  Also, as in other types of patients with CVD, high intensity interval training (HIIT) 
may lead to greater improvements in cardiac structure and function and CRF, as was also evident in one 
of the trials ( N=16) in the Anderson et al7  meta-analysis. Limited data, however, is present in CHD, HF 
or HT regarding "hard" clinical outcomes following HIIT.16-18  Since HT patients achieve peak heart rate 
responses rapidly due to partial or complete denervation following surgery, there is more reason to 
think that HIIT or “burst ET” may be particularly beneficial following HT, potentially more so than for 
other CVD patients. 
 
              This current study also raises several opportunities to “rehabilitate “ CR in HT. The model used is 
an early and one-time event, which discourages repeat or later interventions at time points when 
patients may be more prepared to undergo this type of strategy, later in their course. Also, as discussed 
frequently with CR in CHD, reducing barriers to implementation, such as reducing reliance on having the 
patient come to the CR Center for 36 sessions, and implementing more home-based CR or CR with tele-
communications using digital technologies would also be potentially extremely useful. 1,2  Also, we may 
need to re-think the 36 session model currently utilized throughout CR. Although the Bachmann study 5  
demonstrated that the mean number of CR sessions was increasing over time, Rosenbaum et al 6  study 
suggested a survival benefit beginning at 8 sessions, with incremental benefits on survival associated 
with more sessions. Nevertheless, it is quite possible that near maximal benefit may occur with 16,18, or 
20 sessions , instead of 36, with possibly additional sessions if desired being attended remotely outside 
the CR Center to maximize compliance .Finally, ET-based CR in HT, similar to CHD and HF, has mostly 
focused on aerobic or isotonic ET, whereas muscular mass and strength, which can be increased with 
isometric or resistance ET, could be equally or more important, especially early after HT, to prevent 
frailty , muscle wasting and bone density loss in HT, similar to its potential benefits in patients with 
advanced HF. 15-17 
 
 Finally , we congratulate the authors of the current study for further demonstrating the 
potential benefits of CR in HT to include prevention of hospital re-admissions.    We also applaud the 
HF/HT clinicians across the US for getting a much higher attendance in CRET in their HT patients than we 
have obtained in patients with CHD over many decades.  With further “rehabilitation “ of CR following 
HT, as discussed above, as well as increasing utilization outside the Midwest, we hope to see greater 
“value” in CRET programs to enhance its utilization for more HT recipients. 
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